Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The enzymes of the parasite nuclear division machinery represent a collection of proteins that coordinate the complex process of mitosis and DNA replication in protozoan parasites (Source: NIH, 2017). This group includes essential regulatory kinases such as cyclin-dependent kinases (CDKs), Aurora-related kinases (Arks), and Polo-like kinases (PLKs), as well as structural and catalytic enzymes like topoisomerases, DNA polymerases, and kinesin motor proteins (Source: Frontiers in Cellular and Infection Microbiology, 2020). These enzymes are critical for the survival and proliferation of parasites like Plasmodium falciparum (malaria), Toxoplasma gondii, and kinetoplastids such as Trypanosoma and Leishmania (Source: NIH, 2010). In apicomplexans, the machinery is often organized around a specialized structure called the centrocone or spindle pole body, which coordinates the assembly of the mitotic spindle within the intact nuclear envelope (Source: NIH, 2017). Many of these parasites exhibit unique division modes, such as closed mitosis or schizogony, which rely on specialized machinery that differs significantly from human cell cycle components (Source: Journal of Cell Science, 2004). Consequently, these enzymes are high-priority targets for drug development, as selective inhibition can disrupt the parasite life cycle while minimizing host toxicity (Source: NIH, 2017). Experimental inhibitors of these enzymes, including various kinase and topoisomerase inhibitors, have shown promise in reducing parasite burden and overcoming resistance to conventional therapies (Source: Nature, 2004).
Inhibition of cyclin-dependent kinases, Aurora kinases, and topoisomerases to disrupt DNA replication and mitotic spindle assembly.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enzymes of parasite nuclear division machinery.